ArticleDiscover public health2025
Using multilevel modeling to assess the association between disruption in clinical services during the COVID-19 pandemic and loss of viral suppression among persons with HIV in Washington, DC.
Article in Discover public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: The COVID-19 pandemic created interruptions in healthcare for many people with chronic illnesses, including people with HIV (PWH). Our objective was to assess the association between individual and clinic-level factors and virological suppression throughout the COVID-19 pandemic. Methods: The DC Cohort, a longitudinal cohort study of PWH in Washington, DC, conducted a survey to examine the impact of the COVID-19 pandemic on HIV clinical services between 2019 and 2021. This longitudinal study used clinic and patient characteristics throughout the pandemic to explore changes in virologic suppression (≤ 200 copies/mL) status, comparing pre- (closest lab prior to March 1, 2020) and peri-pandemic time periods (March 1, 2020-December 31, 2021). We assessed prevalence of demographic and clinical characteristics of DC Cohort Study participants, by maintenance of viral suppression peri-pandemic. Multilevel multivariable logistic regression analyses were performed to compare clinic characteristics of those who did and did not maintain virologic suppression during the pandemic. Results: Data were collected from 4018 participants from 14 DC Cohort clinics. Differences in prevalence estimates were found based on clinic-level characteristics. Compared to PWH who were virally suppressed, among PWH with loss of virologic suppression, 14.5% were at a clinic with modified substance abuse counseling (vs. 8.5% of those who were virally suppressed, Conclusion: These findings help identify the impact of pandemic disruptions on clinic operations and PWH's ability to maintain virologic suppression. Reduction in clinic services during the pandemic were associated with loss of virologic suppression status while uptake of telehealth services was associated with maintenance of virologic suppression. The results may help prepare for future pandemic or public health emergencies that disrupt healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.